KMTS
Kestra Medical Technologies, Ltd.NASDAQHealthcare$19.84-1.05%ClosedMarket Cap: $1.16B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.64
P/S
13.83
EV/EBITDA
-6.81
DCF Value
$5.03
FCF Yield
-10.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
48.8%
Operating Margin
-171.5%
Net Margin
-173.0%
ROE
-68.8%
ROA
-38.2%
ROIC
-42.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2026 | $24.6M | 52.6% | $-34.8M | $-34.2M | $-0.61 | — |
| Q2 2026 | $22.6M | 50.6% | $-31.8M | $-32.8M | $-0.64 | — |
| Q1 2026 | $19.4M | 45.7% | $-28.9M | $-25.8M | $-0.50 | — |
| Q4 2025 | $17.2M | 44.3% | $-48.2M | $-52.1M | $-2.21 | — |
| FY 2025 | $59.8M | 40.5% | $-106.4M | $-113.8M | $-5.13 | — |
| Q3 2025 | $15.1M | 43.4% | $-20.6M | $-21.5M | $-0.50 | — |
| Q2 2025 | $14.7M | 39.6% | $-19.1M | $-20.4M | $-0.48 | — |
| Q1 2025 | $12.8M | 32.9% | $-18.4M | $-19.9M | $-0.45 | — |
| Q4 2024 | $10.1M | 13.9% | $-20.3M | $-22.3M | $-0.45 | — |
| FY 2024 | $27.8M | 1.3% | $-85.1M | $-94.1M | $-2.04 | — |
| Q3 2024 | $8.3M | 10.6% | $-19.9M | $-21.6M | $-0.47 | — |
| FY 2023 | $7.6M | -139.6% | $-80.4M | $-84.2M | $-1.75 | — |